Ocular involvement in idiopathic hypereosinophilic syndrome: a rare finding [Augenbeteiligung beim idiopathischen Hypereosinophilen Syndrom: ein seltener Befund]


Autoria(s): Balaskas K.; Wyss P.; Guex-Crosier Y.
Data(s)

2012

Resumo

Hypereosinophilic syndrome (HES) is a myeloproliferative disorder characterised by persistent eosinophilia associated with multiple organ damage. The three criteria required for the diagnosis of the disease are: a sustained absolute eosinophilic count in the serum greater than 1500/μl present for longer than 6 months, no aetiology for secondary eosinophilia present and identification of signs and symptoms of end-organ involvement [1][2]. Despite significant progress in our understanding of the pathogenesis of some forms of hypereosinophilic syndrome, the current state of knowledge is still insufficient to formulate a new comprehensive etiologic definition of HES [3]. Very few reports can be retrieved describing ocular involvement in HES. Retinal arteriolar occlusions were observed in the pre-equatorial region and documented by angiography in one report [4], while the principal defects noted in a second report were occlusions of major retinal vessels, choroidal infarct, and patchy or delayed choroidal filling [5]. We present a case of extensive bilateral choroidal infiltrates in a patient suffering from idiopathic hypereosinophilia, potentially attributable to her disease.

Identificador

http://serval.unil.ch/?id=serval:BIB_22AD31C848E8

isbn:1439-3999 (Electronic)

pmid:22496024

doi:10.1055/s-0031-1299176

isiid:000302788900034

Idioma(s)

en

Fonte

Klinische Monatsblätter Für Augenheilkunde, vol. 229, no. 4, pp. 437-438

Palavras-Chave #Adrenal Cortex Hormones/therapeutic use; Chorioretinitis/diagnosis; Chorioretinitis/drug therapy; Female; Humans; Hypereosinophilic Syndrome/diagnosis; Hypereosinophilic Syndrome/drug therapy; Middle Aged; Rare Diseases; Treatment Outcome; Uveitis/diagnosis; Uveitis/drug therapy
Tipo

info:eu-repo/semantics/article

article